Topic: Biotech

Nearly a year after Intellia Therapeutics showed the world how its CRISPR-based therapy safely edits genes […]

Dive Brief: Bioventus has found a path forward for its stalled takeover of CartiHeal, agreeing to a […]

Genetic medicines in development for blood disorders include several therapies made by taking a patient’s […]

Researchers at the Chalmers University of Technology in Sweden have developed a “polymer brush” system […]

Singapore-based precision gut microbiome company AMILI has snapped up $10.5 million in a Series A […]

  Having been launched earlier this year, the Emboguard balloon guide catheter (Cerenovus) was recently […]

The financial markets continue to be tough for companies looking to raise money, but several […]

In the world of artificial intelligence and machine learning, Google Deepmind’s AlphaGo program defeating world champion […]

Researchers at Northwestern University have created a cardiac pacemaker that dissolves away, negating the need […]

In news that’ll certainly be music to many ears, a surgeon-led team in Texas was […]

The last time Samantha Truex was CEO of a biotech, she did something rare: She […]

Nearly 10% of adults around the world have chronic kidney disease, representing around 700 million […]

Cell therapy started as highly personalized, with treatments made by taking a patient’s own immune […]

Human gut health is closely correlated with mental well-being, various degenerative diseases, and chronic inflammation. […]

BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to […]

Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with […]

Scientists at MIT created a glucose fuel cell that is small and powerful enough to […]

Researchers at the Georgia Institute of Technology have developed a smart stent that can monitor […]

Researchers at Columbia University School of Engineering and Applied Science developed an advanced organ-on-a-chip system […]

Parkinson’s disease patients lack sufficient amounts of a neurotransmitter that plays a key role in […]

Testing giant Quest Diagnostics is diving into the market for blood tests that aid in […]

Bristol Myers Squibb and Merck KGaA are diving deeper into the protein degradation pool, with […]

Norovirus sickens hundreds of millions of people around the world each year, sparking infection that […]

There’s no safe way to get a close-up view of the human heart as it […]

Gandeeva Therapeutics, founded in 2021, is developing precision imaging solutions with the integration of cryo-electron microscopy […]

The first cell therapies for cancer employ T cells turned into targeted tumor fighters. Nkarta […]

Arrowhead and Vivo Capital are forming a new company called Visirna Therapeutics to take four […]

Chalk up another setback to oral selective estrogen receptor degraders (SERDs). In the wake of […]

Scientists at Penn State developed a method to print a ‘bone’ construct during a surgical […]

Biosynthetic cellulose offers potential for applications such as wound dressings, implantable materials, and drug-delivery systems. […]

Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a […]

AbbVie is bowing out of the alpha-synuclein race. Having taken a drug candidate to the […]

Ankyra Therapeutics is bringing on outside expertise to support its bid to unlock the power of cytokines. […]

Integer (NYSE:ITGR) announced today that it acquired Connemara Biomedical and its subsidiaries Aran Biomedical and Proxy Biomedical (collectively […]

Bausch Health’s (NYSE:BHC) Bausch + Lomb and Clearside Biomedical (NSDQ:CLSD) today launched their Xipere product […]

Altos Labs just redefined big in biotech. Where to start? The $3 billion in investor support? The […]

Thermo Fisher Scientific (NYSE:TMO) announced today that it completed its acquisition of PeproTech for approximately $1.85 […]

Amazon (NASDAQ: AMZN) wants to hire key employees to expand its medical diagnostics operations on […]

Biotechs targeting the “don’t eat me” signal cancer cells use to avoid the immune system […]